Noveris Health Sciences is trading at CA$0.10, up +5.26%, with no clear company-specific catalyst identified for September 14, 2026.
- The latest identified announcement, dated September 9, reported shareholder approval of all meeting resolutions, including director elections and the amended incentive plan; it does not directly explain the current gain.
- Broader U.S. markets are weaker, so the move does not clearly align with prevailing market direction.
- Further filings or thin liquidity may explain the intraday change.